NCT04620278View on ClinicalTrials.gov

Genetic Investigation of Cancer Predisposition

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

June 30, 2030

Study Completion Date

December 31, 2035

Conditions
Genetic PredispositionCancer
Interventions
GENETIC

DNA or RNA Sequencing

Samples will be used for whole exome (DNA) or RNA sequencing

Trial Locations (1)

78229

University of Texas Health Science Center, San Antonio

All Listed Sponsors
lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT04620278 - Genetic Investigation of Cancer Predisposition | Biotech Hunter | Biotech Hunter